Celgene-CELG Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG

CELG 108.24

0.0%

Nov 22 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (249)	2/9/1999 9:55:00 PM
From: Miljenko Zuanic	Read Replies (2) of 804

BMY drops ENMD and Angiostatin, after they passed early on Endostatin and canceled thalidomide (because CELG was first in market) . So what is next step. License something (in angiogenesis) which have real perspective. Like CELG's or SUGN's programs. Hope market will not overreact with other cancer companies, but ENMD will be shorted everywhere. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next